Last Updated on October 17, 2024 by The Health Master
New Delhi: Drug firm IOL Chemicals & Pharmaceuticals on Thursday said that it has received nod from the Korean Ministry of Food and Drug Safety for its active pharmaceutical ingredient (API) products:
Ibuprofen and
Fenofibrate.
The approval by the Korean Ministry of Food and Drug Safety re-establishes the company’s efforts to keep the highest quality standards and to increase presence in the regulated markets, IOL Chemicals & Pharmaceuticals said in a regulatory filing.
This will strengthen the company’s presence in the South Korean market, it added.
Ibuprofen is used to treat a range of aches and pains, including back pain, period pain and toothache. Fenofibrate is used to treat the symptoms of high cholesterol and triglycerides in the blood.
Shares of the company closed at Rs 607.55 apiece on BSE, up 1.37 per cent over previous close.
Govt notifies MTP Rules 2021 for abortion up to 24 weeks
NPPA releases proposed retail price calculation for 7 formulations
KSRP urges Govt and PCI to amend admission process to the…
USFDA Staff: Moderna did not meet all criteria for booster dose
Biological E seeks DCGI nod for Phase-III trial of Corbevax
Latest Notifications: Homoeopathic
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
